Skip to main content

Research Repository

Advanced Search

238 The risk of keratinocyte carcinoma (KC) in psoriasis patients receiving biologic therapy compared to conventional systemic therapy: Results from The British Association of Dermatologists Biologic Interventions Register (BADBIR)

Mason, K.J.

Authors



Citation

Mason, K. (2018). 238 The risk of keratinocyte carcinoma (KC) in psoriasis patients receiving biologic therapy compared to conventional systemic therapy: Results from The British Association of Dermatologists Biologic Interventions Register (BADBIR). Journal of Investigative Dermatology, 138(5), S41. https://doi.org/10.1016/j.jid.2018.03.244

Journal Article Type Article
Publication Date 2018-05
Deposit Date Jun 20, 2023
Journal Journal of Investigative Dermatology
Print ISSN 0022-202X
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 138
Issue 5
Pages S41
DOI https://doi.org/10.1016/j.jid.2018.03.244
Keywords Cell Biology; Dermatology; Molecular Biology; Biochemistry
Additional Information This article is maintained by: Elsevier; Article Title: 238 The risk of keratinocyte carcinoma (KC) in psoriasis patients receiving biologic therapy compared to conventional systemic therapy: Results from The British Association of Dermatologists Biologic Interventions Register (BADBIR); Journal Title: Journal of Investigative Dermatology; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jid.2018.03.244; Content Type: simple-article; Copyright: Copyright © 2018 Published by Elsevier Inc.